A patient with idiopathic hypogonadotropic hypogonadism (IHH) had an apparently balanced reciprocal translocation involving chromosomes 13 and 16 [t(13;16)(ql4.ll;q24)j.
Introduction
Idiopathic hypogonadotropic hypogonadism (IHH) is well recognized as a disorder in which hypogonadismcan be associated with several other clinical features including anosmia [Kallmann syndrome ( 1 ) ]. Although it is reported to be compatible with X-linked (2) or autosomal transmission (3), the mode of inheritance of Kallmann syndrome has not been fully elucidated. A locus for IHH has not yet been clarified in humans. Here, we report the first case of sporadic IHHwith chromosomal translocation.
Case Report
The patient, a 22-year-old male ( Fig. 1 II-2 ), first visited our clinic at the age of 21 with the chief complaint of incapability of ejaculation during sexual intercourse. He had libido and penile erections since the age of 14 years, but never had ejaculation. His height was 170 cm and weight 58 kg and his arm span was 173 cm. The facial and body hair were sparse. The penis was small for his age and the testis appeared atrophic. There was no gynecomastia or other anomalities. Other physical examination including olfactory sensation of smell and a complete neurological examination showedno specific findings. Computedtomography and magnetic resonance examinations of the skull were normal. Nosemenanalysis was done before the pulsate administration of luteinizing hormone-releasing hormone (LHRH) because of incapability of ejaculation. Cytogenetic analysis of peripheral blood specimen by using a G-banding method showed balanced reciprocal translocation involving chromosomes 13 and 16 [t(13;16)(ql4.ll;q24)].
His father ( Fig. 1 1-1 ) had the same chromosomal translocation (Fig. 2) , however his physical examination was normal except for divergent strabismus of the left eye. His mother ( Fig. 1 1-2 ) was normal on physical and endocrinological examinations as well as karyotype. Plasma and urine levels of hormones in the patient showed low levels of luteinizing hormone (LH), follicle stimulating hormone (FSH) and testosterone ( Internal Medicine Vol. 32, No. 6 (June 1993) 13 der (13) der (16) 16 13 der (13) der (16) karyotypes of the patient, b: karyotypes of his father. The rearranged chromosomes are der(13)(16q24^16qter::13ql3->13pter) and der(16)(1 3q1 3->1 3qter: : 16q24->16pter).
mone (TSH), prolactin, and growth hormone (GH) level. The patient continued to receive 400 jig ofLHRHfor 7 days. On the eighth day of the study, the last bolus of 100 [ig ofLHRHwas given. Blood specimens again were taken before and 30, 60, 90, and 120 minutes after the last dose ofLHRHfor LH and FSH measurements.
The responses to the releasing hormones are shownin Table  2 . The TSHand prolactin responses to TRHwere normal as was the GHresponse to GRF. The FSH and LH responses to the initial dose ofLHRHwere poor. The peak level ofLH was only 1.3 mlU per ml after the first LHRHinjection, but rose to 12.0 mlU per ml after a daily infusion of LHRHfor a week ( Table  3 ). The peak level ofFSH rose from 3.7 mlUperml afterthe first LHRHinjection to 8.0 mlU per ml after a daily infusion of LHRHfor one week. The pituitary-adrenal axis appeared to be normal because of normal levels of serum adrenocorticotropic hormone (ACTH), serum cortisols, urinary 17-hydroxycorticoids (17-OHCS) and urinary 17-ketosteroids (17-KS).
These results suggested that LHRHdeficiency is isolated and caused by primary hypothalamic dysfunction. Then, LHRH was administered to the patient subcutaneously by using a portable battery-operated pump (SP-3I, NIPURO, Osaka). The dose ofLHRHwas adjusted to a 25 jig dose every 2 hours. After 12 months of LHRHtherapy the serum levels ofLH, FSH and testosterone rose to 3.2, 3.3 and 564, respectively (Table 4) , and the patient becameable to ejaculate. A semenanalysis after 9 months of receiving LHRHtherapy showed a volume of 1.5 ml. Hypogonadismwith ChromosomalTranslocation Table 4 . LH, FSH and Testosterone Levels during the Pulsatile LHRHTherapy LH: luteinizing hormone, FSH: follicle-stimulating hormone, LHRH: luteinizing hormone releasing hormone, NT: not tested. LHRH was administered subcutaneously through a portable battery-operated pump. The dose of LHRH was 25 jig given every 2 hour.
Discussion
Kallmannsyndromeis the most common form of isolated hypogonadotropic hypogonadismin which anosmia or hyposmia is associated with LHRHdeficiency. In the present case, the cause of isolated hypogonadotropic hypogonadism is due to LHRHdeficiency, and the diagnosis of IHHwas made because he has isolated hypogonadotropic hypogonadism with no apparent anosmia or hyposmia. Although the etiology of IHH is unknown, it seems to be related to Kallmann syndrome. The modeof inheritance of Kallmannsyndromeis reported to be Xlinked (2) or autosomal (3). The locus for X-linked Kallmann syndrome has been assigned to Xp22.3 through both physical and genetic mapping (4, 5) . The candidate gene for X-linked Kallmann syndrome was isolated from this region (6, 7) . The chromosomal translocation [t(7; 1 2)(q22;q24)] in a patient with autosomal Kallmannsyndrome was reported (8) . These reports suggest genetic heterogeneity of Kallmann syndrome. However, there is no report on the responsible locus on chromosomes for IHH. In the hypogonadal mouse, a lack of GnRH secretion can be explained by a deletion of a part of the GnRH gene (9) . The genomic structure of GnRHis reported to be normal in patients with IHH including Kallmann syndrome (10) . It is of interest that the present case has no major deletion but balanced translocation found by chromosome analysis. There has been no report on candidate genes for IHHin either chromosome13 or 16, but it is tempting to speculate that the site of this chromosomal translocation might be related to the IHH gene as seen in Aniridia-Wilms' tumor (1 1). This speculation may be obscured by the lack ofIHH in this patient's father who has normal gonadal functions but the same chromosomal abnormalities. This discrepancy could be explained by the difference in penetrance or another additive genetic change in the patient such as genomic imprinting. Genomic imprinting can be defined as the induction of germ-line specific modifications of certain genes, resulting in differential functional expression (12) . The same line of patient was reported by Wanget al (13) , whose patient presented multiple congenital anomalies associated with balanced translocation involving 13 and 14, but her father was phenotypically normal despite the presence of the same chromosomaltranslocation. They investigated the parental origin of chromosomes using genomic probes to detect genomicpolymorphisms, and showed that the patient inherited both chromosomes 14 from her father but none from her mother. Therefore, the chromosome 14 of the patient was uniparental disomy. It was speculated that their patient was phenotypically abnormal because both chromosomes 14 came from imprinted chromosomesof the father. The same approach could be applied to our patient and, then a specific gene responsible for IHHmay be found especially in non-X-linked inheritance.
